World Wealth Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wealth Journal.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on March 28, 2026

Mar. 28, 2026

Satish Sanpal: The Entrepreneur Driving ANAX Holding’s Global Vision from Dubai

EIN Presswire

Mar. 28, 2026

Aftab Uddin Presents Next-Generation AI Risk Model for U.S. Financial Stability and Portfolio Optimization

EIN Presswire

Mar. 28, 2026

The Ultimate Real Estate Hub: Agents and Investors Welcome DPS as the New Heart of Dubai Property

EIN Presswire

Mar. 28, 2026

Sun European Affiliate Completes an Investment in B&H Worldwide Ltd.

EIN Presswire

Mar. 28, 2026

Crypto News Today: Pepeto Project News While Bull Run Signals Align and Dogecoin SEC Commodity Ruling Opens the Door for What Comes Next

GlobeNewswire

Mar. 28, 2026

Ethereum based Pepeto Exchange Update While XRP price retreats to $1.35 support – But recovery Might happen Soon

GlobeNewswire

Mar. 28, 2026

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Lakeland Industries, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LAKE

GlobeNewswire

Mar. 28, 2026

Crypto News of Last 24 Hours: Pepeto Crosses $8.47M While Bitcoin Price Targets $200K and Trump Family $1.2B Profits Reveal Where Insiders Are Moving

GlobeNewswire

Mar. 28, 2026

ThinkCareBelieve: Week 62 of the Trump 2.0 Administration

GlobeNewswire

Mar. 28, 2026

MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting

GlobeNewswire

Mar. 28, 2026

Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity

GlobeNewswire

Mar. 28, 2026

New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis

GlobeNewswire

Mar. 28, 2026

Mulvihill Enhanced Split Preferred Share ETF Announces Year End Results

GlobeNewswire

Mar. 28, 2026

Premium Global Income Split Corp. Announces Year End Results

GlobeNewswire

Mar. 28, 2026

Mulvihill Premium Yield Fund Announces Year End Results

GlobeNewswire

Mar. 28, 2026

FRPT Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Freshpet, Inc. (NASDAQ: FRPT) Investors to Contact the Firm

GlobeNewswire

Mar. 28, 2026

Mulvihill Canadian Bank Enhanced Yield ETF Announces Year End Results

GlobeNewswire

Mar. 28, 2026

Communiqué de presse : AAD : Sanofi présente de nouveaux résultats de phase 3 pour l'amlitelimab dans la dermatite atopique lors d'une session de dernière minute

GlobeNewswire

Mar. 28, 2026

Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session

GlobeNewswire

Mar. 28, 2026

Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting

GlobeNewswire